+444.8%
NVDA vs THC
+258.4%
+186.4%
-66.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.0% | -0.3% | -1.7% | -1.9% |
| 7D | -12.7% | +1.0% | -13.7% | -13.0% |
| 30D | -26.4% | +5.3% | -31.7% | -27.7% |
| 3M | -27.6% | +7.1% | -34.7% | -29.5% |
| 6M | -27.7% | +46.0% | -73.8% | -36.7% |
| YTD | -12.5% | +43.9% | -56.4% | -23.9% |
| 1Y | -12.6% | +45.4% | -58.1% | -24.6% |
| 3Y | +235.9% | +421.3% | -185.3% | +60.9% |
| All | +444.8% | +258.4% | +186.4% | +202.0% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling